CS156880B1 - - Google Patents

Info

Publication number
CS156880B1
CS156880B1 CS81472A CS81472A CS156880B1 CS 156880 B1 CS156880 B1 CS 156880B1 CS 81472 A CS81472 A CS 81472A CS 81472 A CS81472 A CS 81472A CS 156880 B1 CS156880 B1 CS 156880B1
Authority
CS
Czechoslovakia
Application number
CS81472A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CS81472A priority Critical patent/CS156880B1/cs
Publication of CS156880B1 publication Critical patent/CS156880B1/cs

Links

CS81472A 1972-02-09 1972-02-09 CS156880B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS81472A CS156880B1 (en) 1972-02-09 1972-02-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS81472A CS156880B1 (en) 1972-02-09 1972-02-09

Publications (1)

Publication Number Publication Date
CS156880B1 true CS156880B1 (en) 1974-08-23

Family

ID=5340988

Family Applications (1)

Application Number Title Priority Date Filing Date
CS81472A CS156880B1 (en) 1972-02-09 1972-02-09

Country Status (1)

Country Link
CS (1) CS156880B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007503432A (en) * 2003-08-27 2007-02-22 アストラゼネカ・アクチエボラーグ Novel fused N-pyrazinyl-sulfonamides and their use in the treatment of chemokine mediated diseases
WO2007044729A3 (en) * 2005-10-07 2007-08-09 Exelixis Inc N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007503432A (en) * 2003-08-27 2007-02-22 アストラゼネカ・アクチエボラーグ Novel fused N-pyrazinyl-sulfonamides and their use in the treatment of chemokine mediated diseases
WO2007044729A3 (en) * 2005-10-07 2007-08-09 Exelixis Inc N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
US7989622B2 (en) 2005-10-07 2011-08-02 Exelixis, Inc. Phosphatidylinositol 3-kinase inhibitors and methods of their use
EA019255B1 (en) * 2005-10-07 2014-02-28 Экселиксис, Инк. Phosphatidylinositol 3-kinase inhibitors and pharmaceutical compositions containing them
US8889664B2 (en) 2005-10-07 2014-11-18 Exelixis, Inc. Phosphatidylinositol 3-kinase inhibitors and methods of their use

Similar Documents

Publication Publication Date Title
AU465371B2 (en)
CS156880B1 (en)
AU465442B2 (en)
JPS4939173U (en)
JPS4930160U (en)
JPS48105788U (en)
CH571433A5 (en)
CH581850A5 (en)
CH580627A5 (en)
CH580634A5 (en)
CH579535A5 (en)
CH580689A5 (en)
CH580296B5 (en)
CH579419A5 (en)
CH578761B5 (en)
CH578631A5 (en)
CH576979A5 (en)
CH576225A5 (en)
CH581093A5 (en)
NL7311109A (en)
CH576183A5 (en)
CH572668A5 (en)
CH572586A5 (en)
CH571483A5 (en)
CH560870A5 (en)